Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials

By sjmartinez • May 13, 2025

Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, McGovern D, Chan E, Smith MI, Ungaro F, Rieder F, Aden K, Shackelton LM, Massimino L, Neurath M, Allez M, Atreya R, Snapper SB, Raine T, Ahuja V, Haberman Y, Feagan BG, Jairath V, Vande Casteele N. Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials. J Crohns Colitis. 2025 May 8;19(5):jjaf068. doi: 10.1093/ecco-jcc/jjaf068. PMID: 40295219.

Tags: Cedars Sinai DoM, clinical trials, Digestive Diseases, inflammatory bowel disease, Publications, transcriptomic analysis

Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic Breast Cancer: A Brief Report of a Clinical Trial

Henneghan A, Wertheimer J, Kim S, Gresham G, Shirazipour CH, Jones B, Asher A. Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic[...]

CalShock: beyond the shock team, building on California’s cardiogenic shock system of care

Bell FM, Holtzman JN, Chandrakumar HP, Marogi EP, Khedraki R, Cheng R, Elliott A, Hilliard AA, Itchhaporia D, Chonde MD, Naidu SS, Egrie G, Mahmud[...]

Strategies for promoting exercise adherence within a cancer exercise recovery program: a qualitative case study

Huynh N, Cruz N, Torney C, Ruggieri R, Chang P, Asher A, Shirazipour CH. Strategies for promoting exercise adherence within a cancer exercise recovery program:[...]